Related Experiment Video
Updated: Oct 14, 2025

13:14
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
10.6K
Single B cell technologies for monoclonal antibody discovery
Alessandro Pedrioli1, Annette Oxenius1
1Institute of Microbiology, ETH Zürich, Vladimir-Prelog-Weg 4, 8093 Zürich, Switzerland.
Trends in Immunology
|November 8, 2021
Summary
This review explores methods for isolating monoclonal antibodies (mAbs) from single B cells. It discusses techniques for retrieving antibody sequences and generating mAbs independently of B cells, aiding antibody discovery.
Area of Science:
- Immunology
- Biotechnology
- Molecular Biology
Background:
- Monoclonal antibodies (mAbs) are crucial for research and therapeutics.
- Isolating antigen-specific mAbs from short-lived single B cells is challenging.
- Current methods for mAb generation are diverse, necessitating consolidation.
Purpose of the Study:
- To review and discuss major techniques for interrogating antigen-specific single B cells.
- To highlight methods for isolating antigen-specific monoclonal antibodies (mAbs).
- To compare the advantages and disadvantages of various mAb isolation strategies.
Main Methods:
- Review of literature on single B cell interrogation techniques.
- Discussion of miniaturization protocols for antibody sequence retrieval.
- Analysis of alternative mAb generation methods like display technologies and AI algorithms.
Main Results:
- Several techniques facilitate the isolation of antibody-coding sequences from antigen-specific B cells.
- Miniaturization of reaction volumes improves efficiency in B cell interrogation.
- Alternative methods enable mAb generation independent of B cell isolation.
Conclusions:
- A comprehensive understanding of available techniques is needed for efficient antigen-specific mAb isolation.
- The review consolidates information on diverse methods, aiding researchers in selecting optimal strategies.
- Future directions may involve further integration of AI and high-throughput screening for mAb discovery.

